anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Aeglea BioTherapeutics · pitchdeck

Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides

22 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides

Aeglea BioTherapeutics · 2020-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 8 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 2 slides 100% 2/2 slides 100% 2/2 slides · 6 hits
— 0/2 slides
50% 1/2 slides
— 0/2 slides
100% 2/2 slides
— 0/2 slides
Need 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides Satisfaction 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides 100% 2/2 slides Action 2 slides 100% 2/2 slides 100% 2/2 slides · 5 hits
— 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides
— 0/2 slides

Slide inventory

22
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
The slide uses a 3-column layout to map programs to their respective 2020 achievements.show_traction
Open slide detail
04
Uses a process-flow diagram to map strategic pillars to specific risk mitigation areas.present_solution
Open slide detail
05
The chart uses a Gantt-style visualization to represent drug development progress.plan_implementation
Open slide detail
06
Includes regulatory status callout.present_solution
Open slide detail
07
The slide uses a structured table format to define the disease context.frame_problem
Open slide detailBeat · NeedLoop · Pattern Hunter
08
Includes clinical trial data (101A/102A) for Arginase 1 Deficiency.analyze_data
Open slide detailBeat · NeedLoop · Pattern Hunter
09
The chart uses box plots to show median values (389, 171, 127, 112, 99) at different time points.show_traction
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
10
The slide uses a heatmap-style visualization to track individual patient progress across three mobility metrics (6MWT, GMFM-D, GMFM-E).show_traction
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
11
The slide outlines a randomized controlled trial structure with an open-label extension.plan_implementation
Open slide detail
12
The slide uses a map to visualize patient prevalence estimates in specific addressable markets.size_opportunity
Open slide detail
13
plan_implementation
Open slide detail
14
summarize
Open slide detail
15
present_solution
Open slide detail
16
The slide uses a structured table format to define the clinical problem space.frame_problem
Open slide detailLoop · Pattern Hunter
17
frame_problem
Open slide detailLoop · Pattern Hunter
18
Includes a Kaplan-Meier survival curve and a comparative table of clinical manifestations.frame_problem
Open slide detailLoop · Pattern Hunter
19
The chart is a Kaplan-Meier survival curve.present_solution
Open slide detailLoop · Pattern Hunter
20
The slide outlines a multi-cohort trial structure transitioning from IV to SC administration.plan_implementation
Open slide detail
21
present_solution
Open slide detailBeat · Action
22
front_matter
Open slide detailBeat · Action